Interstitial lung abnormalities, coronary heart disease and mortality
Claire C. Cutting(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), Valborg Guðmundsdóttir(University of Iceland), Gregory L. Kinney(Colorado School of Public Health), Michael H. Cho(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Harry B. Rossiter(UCLA Medical Center), Ann-Marcia C. Tukpah(Brigham and Women's Hospital), Jonathan A. Rose(Brigham and Women's Hospital), Hiroto Hatabu(Harvard University), Mizuki Nishino(Brigham and Women's Hospital), Noriaki Wada(Brigham and Women's Hospital), Matthew Moll(Brigham and Women's Hospital), S. Kalra(Brigham and Women's Hospital), Matthew J Budoff(University of California, Los Angeles), George R Washko(Brigham and Women's Hospital), Edwin K. Silverman(Brigham and Women's Hospital), Vilmundur Guðnason(University of Iceland), Heida Bjarnadottir(Icelandic Heart Association), Sigurður Sigurdsson(Icelandic Heart Association)
Cited by 3
Related Papers
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Genome-wide association study of blood pressure and hypertension
|Nature Genetics|2009|1.4k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k